Boulder iQ Names Kevin Horky Vice President of Business Development

Wednesday, February 13, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Kevin Horky joins consulting firm specializing in medical device product development, regulation, quality

BOULDER, Colo., Feb. 13, 2019 /PRNewswire-PRWeb/ -- Boulder iQ has named Kevin Horky vice

president of business development.

Kevin brings extensive experience in the medical device field to Boulder iQ. The company is an expert contract consulting firm for product development, regulatory, clinical, and quality services, specializing in the medical device and in-vitro diagnostic (IVD) industries.

Before joining Boulder iQ, Horky owned and served as president of IPAX, Inc., a contract medical manufacturing company. IPAX streamlined production processes, and created packaging and sterilization processes for medical product companies including: Arthrotech, B. Braun Medical Inc.; Baxa Corporation; Johnson & Johnson; McKinley Medical; On-Gard; Sandoz Inc.; Titmus Optical Inc.; and Venetec International Inc. Horky sold IPAX in 2017. He holds a Bachelor of Arts degree from the University of Minnesota.

"Kevin's focus on bringing products to market, and extensive experience with compliance and quality management systems and manufacturing, has helped clients grow and expand their engineering operations," says Jim Kasic, president and CEO of Boulder iQ. "He is a hands-on professional who provides a broad range of high-performance solutions that address our customers' needs. We are fortunate to have Kevin join us."

About Boulder iQ (http://www.boulderiq.com) Boulder iQ is an expert contract consulting firm for medical and non-medical product development. Based in Boulder, Colorado, Boulder iQ offers design engineering for consumer and industrial products, with complete quality and regulatory services for the medical device and in-vitro diagnostic (IVD) industries.

SOURCE Boulder iQ



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store